The Vanguard Group 13D and 13G filings for Bio-Rad Laboratories, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-20 4:50 pm Purchase | 2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO | The Vanguard Group | 1,907,640 8.370% | 1,716,876 (+900.00%) | Filing |
| 2024-11-12 1:27 pm Unchanged | 2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO | The Vanguard Group | 190,764 8.360% | 0 (Unchanged) | Filing |
| 2024-11-04 11:22 am Sale | 2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO | The Vanguard Group | 190,764 8.360% | -2,236,373 (-92.14%) | Filing |
| 2024-03-11 09:59 am Purchase | 2024-02-29 | 13G | Bio-Rad Laboratories, Inc. BIO | The Vanguard Group | 2,427,137 10.360% | 37,248 (+1.56%) | Filing |
| 2024-02-13 5:00 pm Sale | 2023-12-29 | 13G | Bio-Rad Laboratories, Inc. BIO | The Vanguard Group | 2,389,889 9.930% | -1,547 (-0.06%) | Filing |
| 2023-02-09 11:12 am Purchase | 2022-12-30 | 13G | Bio-Rad Laboratories, Inc. BIO | The Vanguard Group | 2,391,436 9.660% | 103,971 (+4.55%) | Filing |
| 2022-02-09 3:33 pm Purchase | 2021-12-31 | 13G | Bio-Rad Laboratories, Inc. BIO | The Vanguard Group | 2,287,465 9.210% | 15,092 (+0.66%) | Filing |
| 2021-02-10 10:39 am Purchase | 2020-12-31 | 13G | Bio-Rad Laboratories, Inc. BIO | The Vanguard Group | 2,272,373 9.180% | 294,846 (+14.91%) | Filing |
| 2020-02-12 09:26 am Purchase | 2019-12-31 | 13G | Bio-Rad Laboratories, Inc. BIO | The Vanguard Group | 1,977,527 7.960% | 91,462 (+4.85%) | Filing |